Affective Computing for Late-Life Mood and Cognitive Disorders by Erin Smith, Erin Smith, Erin Smith, Erin Smith, Erin Smith, Eric A. Storch, Ipsit Vahia, Ipsit Vahia, Stephen T. C. Wong, Helen Lavretsky, Jeffrey L. Cummings, Harris A. Eyre, Harris A. Eyre, Harris A. Eyre, Harris A. Eyre, Harris A. Eyre, Harris A. Eyre

Get full text

Psychographic Segmentation: Another Lever for Precision Population Brain Health by Erin Smith, Erin Smith, Erin Smith, Erin Smith, Erin Smith, Agustin Ibanez, Agustin Ibanez, Agustin Ibanez, Agustin Ibanez, Agustin Ibanez, Helen Lavretsky, Michael Berk, Michael Berk, Michael Berk, Michael Berk, Harris A. Eyre, Harris A. Eyre, Harris A. Eyre, Harris A. Eyre, Harris A. Eyre, Harris A. Eyre

Get full text

The Evolution of Therapies Targeting Bruton Tyrosine Kinase for the Treatment of Chronic Lymphocytic Leukaemia: Future Perspectives by Toby A. Eyre, John C. Riches

Get full text

“Black box” pharmacogenetic decision-support tools in psychiatry by Chad A. Bousman, Harris A. Eyre

Get full text

Toward a Brain Capital Living Lab model: multi-scale opportunities by Harris A. Eyre, Erin Smith, Agustin Ibanez, Michael Berk

Get full text

Navigating the multiple dimensions of the creativity-mental disorder link: a Convergence Mental Health perspective by David G. Angeler, Erin Smith, Michael Berk, Agustín Ibáñez, Harris A. Eyre

Get full text

Sedentary behavior associated with reduced medial temporal lobe thickness in middle-aged and older adults. by Prabha Siddarth, Alison C Burggren, Harris A Eyre, Gary W Small, David A Merrill

Get full text

Adaptation, Transformation and Resilience in Healthcare; Comment on “Government Actions and Their Relation to Resilience in Healthcare During the COVID-19 Pandemic in New South Wal... by David G. Angeler, Harris A. Eyre, Michael Berk, Craig R. Allen, William Hynes, Igor Linkov

Get full text

Navigating a stable transition to the age of intelligence: A mental wealth perspective by Jo-An Occhipinti, Ante Prodan, William Hynes, Harris A. Eyre, Alex Schulze, Goran Ujdur, Marcel Tanner

Get full text

Complete response of mantle cell lymphoma with central nervous system involvement at diagnosis with acalabrutinib – Case report by Aisling Barrett, Toby A. Eyre, Shaheel Bhuva, Mahmoud Aljurf, Riad El Fakih, Mohammad A. Ashshi, Alfadel Alshaibani

Get full text

Editorial: Precision psychiatry from a pharmacogenetics perspective by Lisa C. Brown, Josiah D. Allen, Josiah D. Allen, Harris A. Eyre, Harris A. Eyre, Bernhard T. Baune, Bernhard T. Baune, Katherine J. Aitchison, Katherine J. Aitchison, Katherine J. Aitchison, Katherine J. Aitchison, Katherine J. Aitchison, Chad A. Bousman, Chad A. Bousman

Get full text

Outcomes of anti-CD38 isatuximab plus pomalidomide and dexamethasone in five relapsed myeloma patients with prior exposure to anti-C38 daratumumab: case series by Faouzi Djebbari, Matt Poynton, Gina Sangha, Laura Anderson, Rebecca Maddams, Toby A. Eyre, Grant Vallance, Supratik Basu, Karthik Ramasamy

Get full text

Innate Resistance and Phosphite Treatment Affect Both the Pathogen’s and Host’s Transcriptomes in the Tanoak-<i>Phytophthora ramorum</i> Pathosystem by Takao Kasuga, Katherine J. Hayden, Catherine A. Eyre, Peter J. P. Croucher, Shannon Schechter, Jessica W. Wright, Matteo Garbelotto

Get full text

P653: OUTCOMES FOLLOWING TREATMENT WITH A COVALENT BTK AND BCL2 INHIBITOR AMONG PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)/SMALL LYMPHOCYTIC LYMPHOMA (SLL): A REAL-WORLD STUD... by T. A. Eyre, L. Hess, T. Sugihara, R. A. Walgren, P. B. Abada, H. Konig, J. Pagel, L. E. Roeker, A. Mato

Get full text

Treatment-free interval as an additional measure of efficacy in a large UK dataset of transplant ineligible myeloma patients. by Faouzi Djebbari, Faye A Sharpley, Susan McLain-Smith, Grant Vallance, Toby A Eyre, Jaimal Kothari, Sally Moore, Karthik Ramasamy

Get full text

The STELLAR trial protocol: a prospective multicentre trial for Richter’s syndrome consisting of a randomised trial investigation CHOP-R with or without acalabrutinib for newly dia... by Niamh Appleby, Toby A. Eyre, Maite Cabes, Aimee Jackson, Rebecca Boucher, Francesca Yates, Sonia Fox, Andrew Rawstron, Peter Hillmen, Anna Schuh

Get full text

Correction: Long-term clinical outcomes in a cohort of patients with solitary plasmacytoma treated in the modern era. by F A Sharpley, P Neffa, F Panitsas, T A Eyre, J Kothari, M Subesinghe, D Cutter, R Shcolnik Szor, G Aparedcida Martinez, V Rocha, K Ramasamy

Get full text

Building systemic resilience, productivity and well-being: a Mental Wealth perspective by Adam Skinner, Ian B Hickie, Yun Song, Ante Prodan, William Hynes, John Buchanan, Jo-An Occhipinti, Patricia Geli, Harris A. Eyre, Goran Ujdur, Roy Green, Sebastian Rosenberg, Allan Fels

Get full text

PB1863: BRUIN CLL-322: A PHASE 3 OPEN-LABEL, RANDOMIZED STUDY OF FIXED DURATION PIRTOBRUTINIB+VENETOCLAX AND RITUXIMAB VS VENETOCLAX AND RITUXIMAB IN PREVIOUSLY TREATED CLL/SLL (TR... by A. R. Mato, W. G. Wierda, J. M. Pagel, M. S. Davids, P. L. Zinzani, Y. Lu, H. Liu, S. Shahda, C. C. Leow, C. S. Tam, J. A. Woyach, T. A. Eyre

Get full text

P618: LONG-TERM SAFETY WITH ≥12 MONTHS OF PIRTOBRUTINIB IN RELAPSED/REFRACTORY (R/R) B-CELL MALIGNANCIES by Wojciech Jurczak, Catherine C. Coombs, Nirav N. Shah, Jennifer Woyach, Chan Y. Cheah, Krish Patel, Kami Maddocks, Yucai Wang, Catherine E. Muehlenbein, Chunxiao Wang, Sarang Abhyankar, Donald E. Tsai, Toby A. Eyre

Get full text